MedTrace Logo

Effect of Armolipid on Lipid Profile in Children With Hypercholesterolemia

NCT06045377 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-09-21

No results posted yet for this study

Summary

Data concerning the effectiveness od nutraceuticals in children with dyslipidemia are lacking. The aim of the present study was to evaluate the efficacy and safety of the long-term use of a dietary supplement containing red yeast rice (RYR), combined with other natural compounds, in children and adolescents with hypercholesterolemia.

A nutraceutical, containing RYR, polycosanols, coenzyme Q10, astaxanthin and folic acid (commercial name: Armolipid), was administered once-daily in 84 children/adolescents with moderate or severe hypercholesterolemia.

Conditions

  • Dyslipidemias
  • Children, Only

Interventions

DIETARY_SUPPLEMENT

Effect of Armolipid on Lipid Profile in Children With Hypercholesterolemia

A prospective single center cohort study

Sponsors & Collaborators

  • Athens General Children's Hospital "Pan. & Aglaia Kyriakou"

    lead OTHER

Principal Investigators

  • Achilleas Attilakos, Assoc.Prof · Athens Children's Hospital Pan. and Aglaia Kyriakou

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
7 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-20
Primary Completion
2022-06-25
Completion
2022-09-05

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06045377 on ClinicalTrials.gov